Skip to content
    FSLR
    Earnings call· Mar 2026(Q1 FY26)

    FIRST SOLAR Q1 FY26 earnings call FSLR

    Apr 30, 2026 Source

    Executive summary

    First Solar Q1 FY26 — Record Revenue, Margin Expansion, and CuRe Launch

    First Solar delivered a strong Q1 FY26, marked by record revenue and significant margin expansion, driven by increased volume and Section 45X tax benefits. The company is progressing its technology roadmap with the CuRe launch and maintaining a disciplined approach to bookings amidst policy uncertainties. International operations face headwinds from reduced utilization and trade dynamics, while domestic manufacturing and IP enforcement remain strategic priorities.

    Highlights

    5
    • Record Q1 revenue of $1 billion, representing a 24% year-over-year increase.

    • Gross margin expanded by 6 percentage points year-over-year to 47%.

    • Adjusted EBITDA reached $520 million, exceeding the high end of the preview range of $400 million to $500 million.

    • Contracted backlog stands at 47.9 gigawatts with an aggregate transaction price of $14.4 billion, with deliveries through 2030.

    • CuRe technology launch is complete in Perrysburg, with the first Series 6 line ramping consistent with expectations.

    Concerns

    3
    • International facilities in Malaysia and Vietnam are operating at significantly reduced utilization due to current trade dynamics and lower ASP expectations.

    • Operating cash outflows of $215 million were reported in Q1 FY26.

    • Uncertainty surrounds the future tariff environment after Section 122 tariffs expire in July, with no clear modeling for potential 301 tariffs.

    Guidance & targets

    6
    CategoryTargetConfidence
    Full-year 2026 guidance
    Remains unchanged
    high materiality
    High
    Q2 2026 volumes sold
    3.4 GW to 4 GW
    medium materiality
    High
    Q2 2026 Adjusted EBITDA
    $400 million to $500 million
    high materiality
    High
    Additional revenue from technology adjusters
    Up to $0.6 billion
    medium materiality
    Medium
    Warehouse costs
    Approximately $100 million
    low materiality
    High
    Full-year underutilization costs
    $115 million to $155 million
    medium materiality
    High

    Operational metrics

    26
    Non-GAAP EPS
    $3.22up 65% YoY
    Q1 FY26

    Diluted EPS for the quarter.

    Adjusted EBITDA
    $520 millionabove high end of $400M-$500M preview range
    Q1 FY26

    Exceeded the company's preview range.

    Adjusted EBITDA margin
    50%
    Q1 FY26

    Margin for the quarter.

    Net sales
    $1 billionup 24% YoY
    Q1 FY26

    Record first quarter net sales.

    Volume sold
    3.8 GW
    Q1 FY26

    Total volume sold in the quarter.

    Volume increase
    31%YoY
    Q1 FY26

    Increase in volume sold year-over-year, partially offset by lower average sales price due to higher India deliveries.

    Gross margin
    47%expanded 6 percentage points YoY
    Q1 FY26

    Expanded due to Section 45X benefits and lower freight costs, partially offset by higher India mix and increased tariff costs.

    Sales freight costs
    $0.017approximately half of Q1 FY25
    Q1 FY26

    Reduced freight costs, including lower detention and demurrage.

    Warehouse costs reduction
    $22 millionsequential reduction from Q4 FY25
    Q1 FY26

    Part of a plan to rationalize warehouse costs to approximately $100 million by 2027.

    Operating expenses
    $141 million
    Q1 FY26

    Total operating expenses for the quarter.

    R&D expenses
    $67 millionup $15 million YoY
    Q1 FY26

    Primarily reflecting perovskite development and ongoing CuRe launch work.

    Cash and investments balance
    $2.4 billion
    as of March 31, 2026

    Includes cash, cash equivalents, restricted cash and marketable securities.

    Net cash position
    $2 billion
    as of March 31, 2026

    At the high end of the targeted resilient net cash range of approximately $1.5 billion to $2 billion.

    Operating cash outflows
    $215 milliondecrease from $608 million in Q1 FY25
    Q1 FY26

    Reflected normal first quarter working capital dynamics.

    Capex
    $119 million
    Q1 FY26

    Primarily for the South Carolina finishing facility.

    India DFC loan principal payment
    $45 million
    Q1 FY26

    Scheduled principal payment completed.

    U.S. facilities utilization
    96%
    Q1 FY26

    Utilization rate for U.S. manufacturing facilities.

    Modules produced
    4.3 GW
    Q1 FY26

    Total module production for the quarter, split by geography.

    India sales volume
    1 GW
    Q1 FY26

    Volume sold domestically in India in a book-and-bill market.

    India average selling price
    $0.20
    Q1 FY26

    Average selling price for modules sold in India.

    U.S. utility-scale market ASP
    $0.35
    call-to-call

    Average selling price for 1.4 GW booked since the last earnings call, inclusive of applicable adjusters.

    Adders on ASP
    $0.015
    Q1 FY26

    Blended average of adders, noting a transition where CuRe attributes are increasingly embedded in the base price.

    Domestic content bonus value
    $0.15 or $0.20
    current

    Value to customers for enabling the domestic content bonus for Investment Tax Credits (ITC).

    Underutilization charges
    moresequential
    Q2 FY26

    Expected due to lower utilization rates for international facilities in Q2.

    Remaining CadTel capacity in Southeast Asia
    slightly less than 2 GW
    current

    Capacity in play for fully manufactured modules from Malaysia/Vietnam, after accounting for capacity supporting South Carolina and perovskite pilot line.

    Perovskite pilot line capacity
    1 GW
    2027

    Capacity of the planned perovskite pilot line.

    Industry KPIs

    5
    MetricValueDetails
    Backlog order book47.9 GWGW
    Fab capacity utilization96%%
    Bookings net order intake1.7 GWGW
    Node platform ramp scheduleCuRe launch complete; Perovskite pilot line running
    End market segment revenue mixIndia sales: 1 GW; U.S. utility-scale market ASP: $0.35/watt

    Orderbook & backlog

    10
    Contracted backlog47.9 GWMarch 31, 2026

    Aggregate transaction price of $14.4 billion, exclusive of technology adjusters, with deliveries through 2030.

    Volume sold3.8 GWQ1 FY26
    Gross bookings1.7 GWQ1 FY26
    Debookings0.1 GWQ1 FY26
    U.S. gross bookings0.9 GWQ1 FY26

    At an average selling price of approximately $0.34 per watt inclusive of applicable adjusters.

    India gross bookings0.8 GWQ1 FY26
    Gross bookings (call-to-call)1.9 GWsince last earnings call

    Excluding domestic India volume.

    U.S. utility-scale market bookings (call-to-call)1.4 GWsince last earnings call

    At an ASP of approximately $0.35 per watt, inclusive of applicable adjusters.

    Option volume700 MWcurrent

    Related to M&A activity, expected to be exercised over the next several quarters upon acquisition completion.

    International Series 6 backlog~5 GWentering FY26

    Multi-year backlog with shipments across 2026, 2027, and 2028.

    Product announcements

    2
    ProductTypeDetails
    CuRe Technologylaunch
    Perovskite Pilot Lineroadmap

    Capital programs

    2
    South Carolina finishing facilityunderway
    Period spend: $119 million
    Start: Q1 FY26

    Benefit: Finishing capacity for Series 6 modules, optimize freight, tariff, and domestic content outcomes, benefit from Section 45X tax credits.

    Equipment installation began in Q1 FY26, on track for production start in the second half of 2026.

    Perovskite pilot lineunderway

    Benefit: 1 GW capacity, field validation of perovskite performance and durability.

    A 1 gigawatt pilot line will be running in 2027 at the Perrysburg facility, leveraging existing space and capabilities. This is a development effort to validate the technology.

    Risks & headwinds

    5
    International Facility UnderutilizationQ1 FY26 and ongoing

    Malaysia and Vietnam facilities operating at significantly reduced utilization

    Mitigation: Maintaining option around capacity, awaiting policy clarity (e.g., 232) to spur demand for fully finished international product.

    Tariff Uncertaintypost-July FY26

    Section 122 tariffs expire end of July; no modeling for potential 301 tariffs beyond that

    Mitigation: Focusing on India market with strong demand and attractive gross margins; evaluating bringing limited WIP share product from India to U.S.

    Policy and Regulatory DelaysQ2 FY26 expected resolution for 232, but potential for delays

    Selective approach to U.S. bookings due to pending Section 232 polysilicon derivatives tariff decision and proposed FEOC rulemaking

    Mitigation: Engaging with administration on proposed 232 framework; maintaining pricing discipline in U.S. market.

    IP Infringement RiskOngoing

    Most TOPCon products infringe First Solar's IP

    Mitigation: Willingness to engage in commercial licensing conversations for IP; Section 337 investigation instituted with initial determination within 11 months.

    India Efficiency ThresholdsBeginning 2027

    Proposal to increase minimum efficiency of PV modules for ALMM beginning 2027

    Mitigation: Launching CuRe in India beginning of next year to improve efficiency and enhance energy attributes; constructive dialogue with MNRE on value of energy attributes.

    What to watch in Q2 FY26

    5

    Section 232 polysilicon derivatives tariff decision

    Q2 FY26
    CurrentPending
    TargetResolution/Communication of outcome

    Why it matters

    Will impact pricing, demand, and risk allocation for international product, influencing future bookings strategy.

    The outcomes there could be, we continue to run that product at full capacity end to end and ship fully finished goods into the U.S. it could be that there's demand, we could add an incremental finishing line in the U.S. and finish that capacity here? Or it could be that neither occur and then we're into the potential shutdown of that capacity.

    Q&A highlights

    10

    Why are Q2 margins flattish despite freight/warehouse improvements? What tailwinds for 3Q/4Q? And clarification on recent ASPs ($0.36-$0.37/watt implied by analyst).

    Alex Bradley explains that India mix doesn't materially impact percentage gross margin. Second half should be stronger due to incremental volume and potential tariff changes. Mark Widmar clarifies recent bookings ASPs are $0.35/watt for call-to-call volume, with some M&A activity driving demand.

    The average ASP for the call-to-call volume of that 1.4 was $0.35.

    asked by Brian Lee · answered by Mark Widmar

    3 min read6 chapters

    Detailed Narrative

    01

    CuRe Technology Rollout

    First Solar's CuRe technology launch is complete in Perrysburg, with the first Series 6 line ramping consistent with expectations. This technology is central to the company's strategy, validated by extensive testing data for its bifaciality, advantaged temperature coefficient, and degradation profile. CuRe is anticipated to deliver up to 8% more lifetime specific energy yield than crystalline silicon Topcon. The replication of CuRe across the Series 6 and 7 fleet is scheduled through the first half of 2028, which could support up to $0.6 billion of additional revenue from technology adjusters in the backlog, with the majority expected in 2027 and 2028.

    02

    Manufacturing Operations & Utilization

    In Q1 FY26, First Solar produced 4.3 gigawatts of modules, with approximately 3 gigawatts originating from U.S. facilities, which operated at approximately 96% utilization. The remaining 1.3 gigawatts came from the international fleet. The South Carolina finishing facility is on track for production start in the second half of 2026, with equipment installation commencing this quarter. This facility is designed to provide finishing capacity for Series 6 modules initiated at international factories, optimizing freight, tariff, and domestic content outcomes while benefiting from Section 45X module assembly tax credits. International facilities in Malaysia and Vietnam continue to operate at significantly reduced utilization due to trade dynamics and lower ASP expectations.

    03

    Strategic Market Positioning

    First Solar's competitive position in the United States and India is strengthening, underpinned by its differentiated technology, domestic manufacturing footprint, and independence from Chinese crystalline silicon supply chains. In the U.S., headwinds for crystalline silicon are increasing, including trade remedy enforcement, indications of restricted FEOC regulations, and ongoing intellectual property litigation. Specifically, the U.S. International Trade Commission has instituted a Section 337 investigation, with an initial determination expected within 11 months and a final decision within 15 months. This strategic approach aims to leverage the company's unique attributes in key markets.

    04

    India Market Dynamics

    The company's presence in India reflects a strategic logic similar to its U.S. manufacturing investment, focusing on energy security and supply chain independence. The policy framework in India, including the existing Approved List of Models and Manufacturers (ALMM) and anticipated implementation of ALMM at the cell level, along with domestic content requirements, currently favors vertically integrated manufacturers like First Solar. Near-term demand is robust, supported by both utility-scale and distributed solar applications, particularly in agricultural land developments where CadTel technology's energy yield in hot, humid conditions provides a meaningful differentiator. In Q1, First Solar sold approximately 1 gigawatt in India at an average selling price of approximately $0.20 per watt.

    05

    Policy and Regulatory Matters

    First Solar is maintaining a highly selective approach to incremental U.S. bookings, awaiting clarity on key policy and regulatory matters. These include the pending Section 232 polysilicon derivatives tariff decision and proposed FEOC rulemaking. Management indicates that engagements with the administration regarding the 232 framework are positive, with proposals for a $0.01 per watt tariff on cells/modules or a minimum import price. The company expects a resolution on the 232 tariff by the end of Q2, though acknowledges potential for delays depending on other events.

    06

    Perovskite Development

    First Solar is on track to run a 1 gigawatt perovskite pilot line in 2027. This pilot line will be located in the Perrysburg facility, leveraging existing infrastructure and capabilities. The initial focus for this higher-cost product will be on field validation, customer feedback, and assessing performance, degradation, and bankability under various conditions. The company is evaluating different product constructs, including single junction and tandem, but prioritizes validating the durability and viability of the perovskite layer itself before addressing the complexities of tandem integration.

    AI-generated summary of the company’s earnings call. Not investment advice.